Dean W. Felsher

A tumor-immune mathematical model of CD4+ T helper cell dependent tumor regression by oncogene inactivation

David S. Paik, Kavya Rakhra, Chinyere I. Nwabugwu, 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Christopher H. Contag, Stefanie Mandl, Dean W. Felsher, 2004, Nature.

Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis

Debashis Sahoo, David L. Dill, Dean W. Felsher, 2008, PLoS genetics.

Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

Dean W. Felsher, D. Felsher, P. Bachireddy, 2007, Proceedings of the National Academy of Sciences.

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

Ji Luo, David F. Stroncek, Chi Ma, 2016, Nature.

Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas

Dean W. Felsher, Jeffrey A. Whitsett, D. Felsher, 2008, PloS one.

Cancer revoked: oncogenes as therapeutic targets

Dean W. Felsher, D. Felsher, 2003, Nature Reviews Cancer.

Survival and Death Signals Can Predict Tumor Response to Therapy After Oncogene Inactivation

Lawrence H. Schwartz, Nicholas P. Hughes, Dean W. Felsher, 2011, Science Translational Medicine.